Intelligent Bio Solutions Commences Clinical Studies To Support FDA 510(k) Submission For U.S. Market Clearance Of Intelligent Fingerprinting Drug Screening System
Benzinga Newsdesk 9 months ago
BiotechNewsFDAGeneral
Clinical studies designed to support FDA clearance and planned commercial launch into the world's largest drug screening market Company anticipates full data analysis by the end of March 2026; data to be
Clinical studies designed to support FDA clearance and planned commercial launch into the world's largest drug screening market
Company anticipates full data analysis by the end of March 2026; data to be incorporated into FDA 510(k) submission package